Document Detail

EGFR and ErbB2 differentially regulate Raf-1 translocation and activation.
MedLine Citation:
PMID:  11796827     Owner:  NLM     Status:  MEDLINE    
Epidermal growth factor receptor (EGFR) and HER-2/ErbB2 are members of the Erb family of signaling receptors. ErbB2 is overexpressed in many different cancers and has been linked to enhanced malignancy of tumors. We have examined the cellular translocation of Raf-1 during EGF-dependent signal transduction in two breast tumor cell lines, BT20 and SKBR3. Treatment of BT-20 breast cancer cells, which express EGFR, with EGF resulted in rapid (5 minutes) accumulation of EGFR and Raf-1 into plasma membrane-associated endocytotic vesicles. However, at later time points (30 minutes) only EGFR was endocytosed and Raf-1 dissociated from the plasma membrane and was found in the cytosol. In SKBR3 breast cancer cells, which express high levels of EGFR and ErbB2, treatment with EGF also resulted in rapid accumulation of EGFR and Raf-1 into endocytotic vesicles, but EGFR endocytosis was inhibited and Raf-1 remained associated with the plasma membrane for a prolonged period. The role of ErbB2 in the retention of Raf-1 at the plasma membrane was confirmed in BT-20 cells transfected with ErbB2. BT-20 cells expressing ErbB2 and treated with EGF retained Raf-1 at the plasma membrane for prolonged periods, whereas Raf-1 rapidly dissociated from the plasma membrane in EGF-stimulated cells transfected with a control vector. The presence of Raf-1 at the plasma membrane correlated with activation of Raf-1 and MAP kinase. Cells that expressed ErbB2 and treated with EGF showed prolonged activation of Raf-1 and MAP kinase compared with cells that expressed low levels of ErbB2. These results suggest that expression of ErbB2 promoted retention of Raf-1 in the plasma membrane, resulting in prolonged activation of the MAP kinase cascade, which may contribute to enhanced malignancy in ErbB2-expressing cancers.
Lianfeng Zhang; Mary Bewick; Robert M Lafrenie
Related Documents :
11745477 - Zd1839 (iressa), a novel epidermal growth factor receptor (egfr) tyrosine kinase inhibi...
18462377 - Lack of somatic erbb2 tyrosine kinase domain mutations in hepatocellular carcinoma.
20927317 - A critical role of c-cbl-interacting protein of 85 kda in the development and progressi...
19887107 - Egf-induced tyrosine phosphorylation of endofin is dependent on pi3k activity and prope...
19170657 - Lipid rafts enriched in phosphatidylglucoside direct astroglial differentiation by regu...
9130707 - Convergence of map kinase pathways on the ternary complex factor sap-1a.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Laboratory investigation; a journal of technical methods and pathology     Volume:  82     ISSN:  0023-6837     ISO Abbreviation:  Lab. Invest.     Publication Date:  2002 Jan 
Date Detail:
Created Date:  2002-01-17     Completed Date:  2002-02-14     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0376617     Medline TA:  Lab Invest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  71-8     Citation Subset:  IM    
Division of Tumor Biology, Northeastern Ontario Regional Cancer Centre, 41 Ramsey Lake Road, Sudbury, Ontario, Canada P3E 5J1.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Breast Neoplasms
Cell Membrane / metabolism
Cytosol / metabolism
Epidermal Growth Factor / pharmacology*
Gene Expression Regulation
Protein Transport
Proto-Oncogene Proteins c-raf / metabolism*
Receptor, Epidermal Growth Factor / genetics,  physiology*
Receptor, erbB-2 / genetics,  physiology*
Recombinant Proteins / metabolism
Signal Transduction / physiology
Tumor Cells, Cultured
Reg. No./Substance:
0/Recombinant Proteins; 62229-50-9/Epidermal Growth Factor; EC, Epidermal Growth Factor; EC, erbB-2; EC Proteins c-raf

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Selectin-mediated interactions regulate cytokine networks and macrophage heme oxygenase-1 induction ...
Next Document:  Severity of elastase-induced emphysema is decreased in tumor necrosis factor-alpha and interleukin-1...